What is BMAC treatment and how does it work?

Bone marrow aspirate concentrate (BMAC) is an autologous treatment where marrow harvested from your pelvic bone is centrifuged to concentrate mesenchymal stem cells, platelets, and anti-inflammatory cytokines, which are then injected into your arthritic knee joint to relieve pain and support joint function.

Who is an ideal candidate for BMAC treatment in Lahore?

Ideal candidates are generally patients with mild to moderate knee osteoarthritis (Kellgren–Lawrence grade II–III) who have persistent symptoms despite conservative care and wish to delay or postpone joint replacement surgery.

How long do the benefits of a BMAC injection typically last?

Clinical literature reviewed in Medicina (2025) indicates that pain relief and functional improvements from BMAC commonly last 18 months or longer, though individual responses vary depending on joint damage severity and patient activity.

Can BMAC rebuild destroyed knee cartilage completely?

No. BMAC cannot regrow destroyed cartilage or reverse end-stage arthritis. It is designed to reduce inflammation, improve mobility, and buy healthy years before definitive joint surgery might become necessary.

Regenerative Orthopaedic Care

BMAC Treatment Lahore: Non-Surgical Joint Care

Bone marrow aspirate concentrate (BMAC) uses your body's own regenerative cellular fraction to manage joint pain and slow arthritis progression. Dr Farooq Azam Khan provides the first BMAC programme in Lahore to help suitable patients preserve joint function and buy healthy years before definitive surgery.

For patients considering BMAC treatment Lahore offers a non-surgical biological approach to joint preservation. Bone marrow aspirate concentrate (BMAC) is an autologous orthopaedic procedure that uses concentrated regenerative cells from a patient's own bone marrow to reduce joint inflammation and support tissue healing. Concentrated to deliver mesenchymal stem cells (MSCs), platelets, and bioactive growth factors, it is injected directly into an arthritic joint to manage chronic pain and preserve mobility.

The First BMAC Programme in Lahore

Dr Farooq Azam Khan offers the first BMAC programme in Lahore, built on international protocols adapted into in-house clinical guidelines. The primary clinical objective for patients with moderate knee osteoarthritis is to buy healthy, active years before definitive joint surgery is considered. By delivering an autologous cellular concentrate directly into the joint, BMAC works to calm inflammatory pathways, alleviate joint stiffness, and support long-term mobility.

The Three-Step BMAC Procedure

BMAC is performed as a same-day clinical procedure under strict sterile precautions in an operating theatre setting across three distinct stages:

Harvest

Under local anaesthesia, a small volume of bone marrow is aspirated from the posterior iliac crest (the pelvic bone) using specialised needle guidance to minimise discomfort.

Concentrate

The harvested aspirate is processed in a specialised centrifuge within the sterile field, isolating mesenchymal stem cells, platelets, and signalling cytokines.

Inject

The concentrated BMAC is precisely injected into the affected joint space, delivering concentrated anti-inflammatory and regenerative bioactive factors directly to the joint.

Who Is a Candidate for BMAC Treatment Lahore?

Patient selection is critical to achieving realistic outcomes. Clinical examination and weight-bearing radiographs determine whether your joint is suited for biological preservation:

Suitable Candidates: Patients with mild to moderate knee osteoarthritis (Kellgren–Lawrence grade II–III) who experience pain despite conservative care and wish to postpone joint replacement surgery.
Who Is Not a Candidate: Patients with end-stage osteoarthritis (Kellgren–Lawrence grade IV with substantial bony deformity), active joint or systemic infections, severe haematological disorders, or individuals expecting complete cartilage regrowth.

Understanding the Clinical Evidence and Limitations

Honest patient education requires clarity regarding what scientific evidence demonstrates. Clinical trials reviewed by Park et al. in Medicina (2025) indicate that BMAC provides meaningful medium-term pain reduction and functional improvement for many patients. In a 4-year prospective study published by Pabinger et al. (Scientific Reports, 2024), patients with grade III and IV knee osteoarthritis experienced significant score improvements (WOMAC pain-and-function score improved from 40 to 18) with zero knees undergoing joint replacement across the 4-year period (though the study lacked a blinded placebo control).

However, international literature reviews, such as Medicina (2025), note that one placebo-controlled trial found no significant difference in pain reduction between BMAC and saline injections (p > 0.09). Furthermore, without clinical follow-up of five or more years and serial MRI cartilage evaluations, it remains unproven whether BMAC exerts a true, permanent disease-modifying effect. BMAC is a therapeutic tool to alleviate symptoms and buy time; it does not regrow pristine cartilage or promise that joint replacement will never be needed.

Procedure Investment and Pricing Context

The dedicated fee range for a BMAC procedure conducted under sterile theatre conditions is outlined below:

PKR 50,000 to PKR 150,000 per treated joint, priced in line with published Lahore market rates for autologous single-joint cell treatment (market rates, August 2026). Treating both knees in the same sitting, and any imaging needed before a decision can be made, are the factors that move a given case within that band.

For broader context, total knee replacement in Lahore typically ranges from PKR 400,000–900,000 (Lahore market range, August 2026). Published ranges serve as general market guidance rather than a binding quote, and a definitive financial plan is established during consultation.

Signs Generally Regarded as Needing Urgent Evaluation

Certain acute signs require urgent medical evaluation rather than an elective clinic appointment. These include the inability to bear any weight on the leg, sudden and tense joint swelling developing within hours, a locked joint that cannot be straightened mechanically, or joint pain accompanied by fever, spreading skin warmth, and redness.

Consultation and Next Steps

To explore joint preservation options, review our guide to alternatives to knee replacement, evaluate surgical timing in when is it time for knee replacement, or browse all orthopaedic services. A consultation with Dr Farooq Azam Khan at his Lahore clinics provides a personalised clinical assessment tailored to your joint health.

Book a consultation

Common questions

What is BMAC treatment and how does it work?: Bone marrow aspirate concentrate (BMAC) is an autologous treatment where marrow harvested from your pelvic bone is centrifuged to concentrate mesenchymal stem cells, platelets, and anti-inflammatory cytokines, which are then injected into your arthritic knee joint to relieve pain and support joint function.
Who is an ideal candidate for BMAC treatment in Lahore?: Ideal candidates are generally patients with mild to moderate knee osteoarthritis (Kellgren–Lawrence grade II–III) who have persistent symptoms despite conservative care and wish to delay or postpone joint replacement surgery.
How long do the benefits of a BMAC injection typically last?: Clinical literature reviewed in Medicina (2025) indicates that pain relief and functional improvements from BMAC commonly last 18 months or longer, though individual responses vary depending on joint damage severity and patient activity.
Can BMAC rebuild destroyed knee cartilage completely?: No. BMAC cannot regrow destroyed cartilage or reverse end-stage arthritis. It is designed to reduce inflammation, improve mobility, and buy healthy years before definitive joint surgery might become necessary.

← All services